A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

NCT06953323 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: WJB001 Capsules+Paclitaxel/Paclitaxel-albumin
DRUG: WJB001 Capsules+carboplatin/Nedaplatin
DRUG: WJB001 Capsules+Paclitaxel+carboplatin
DRUG: WJB001 Capsules+Niraparib
DRUG: WJB001 Capsules+Bevacizumab
DRUG: WJB001 Capsules+JS207/JS001
DRUG: WJB001 Capsules+Paclitaxel+carboplatin+JS207/Toripalimab

Sponsor

Wigen Biomedicine Technology (Shanghai) Co., Ltd.